Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Marvell is boosting its forecasts, but that’s not enough to lift its stock

The chip maker didn’t offer much upside to estimates with its July-quarter results.

Marvell is boosting its forecasts, but that’s not enough to lift its stock

We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at marketwatch.com →

More in Finance & Markets

Kane Biotech Announces Second Quarter 2026 Financial Results

WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results.

  • Kane Biotech reports Q2 2026 financial results
  • Company cautions on risks impacting outcomes
  • Details in disclosure documents at www.sedarplus.ca

More from Thursday 27 August →